Rapalogs have been extensively evaluated for the treatment of many other tumor types, but such investigations have met with very limited clinical success, despite the fact that the PI3K/AKT/mTOR pathway is frequently dysregulated in human cancers and it plays a fundamental biological role as a master regulator of cell growth and proliferation, cellular metabolism, and cell survival [174]. This evidence concerns the gene AKT1 and cancer.